All Events
The National Heart, Lung, and Blood Institute (NHLBI), in partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA), hosts Research That Heals: Partnering with Patients to Transform SCD Care on June 25-26, 2026, to discuss and...
The National Heart, Lung, and Blood Institute (NHLBI), in collaboration with the U.S. Food and Drug Administration's Center for Devices and Radiological Health (FDA/CDRH), will convene a virtual workshop focused on regulatory science approaches to...
The National Institutes of Health invite your participation as a supported speaker in a public conference titled 2026 NIH Research Conference on Sleep and the Health of Women (SHOW 2026). This three-day conference is designed to highlight recent...
National Institutes of Health
Natcher Conference Center, Ruth L. Kirschstein Auditorium
45 Center Dr.
Bethesda, MD 20894
United States
Retirement symposium honoring Dr. James R. Sellers’ contributions to myosin studies. Leading scientists in the field will be present.
NIH
10 Center Dr
Building 10, Lipsett Amphitheater
Bethesda, MD 20892
United States
The 19th annual Sickle Cell in Focus (SCiF) conference will be held September 24-25 2026. Registration is free!
Despite progress in understanding the role of the 3Is in CVD, gaps persist in effectively translating research into practice. The integration of machine learning (ML), artificial intelligence (AI), and designer drug development into cardiovascular...
The Future Directions in Sickle Cell Disease Using Network Medicine and AI Integration workshop will take place September 15–16, 2026. Attendees will be invited to attend the workshop virtually via NIH VideoCast. The overarching goals of the...
The National Heart, Lung, and Blood Institute is hosting the virtual workshop "Methamphetamine-Associated Pulmonary Arterial Hypertension (PAH): Diagnosis, Prevalence, Susceptibility, and Therapy" on August 28, 2026.
The purpose of this meeting was to seek guidance and gather input from the Sleep Disorders Research Advisory Board on research priorities conducted or supported by the Institute; to update the Advisory Board and public stakeholders on the progress of...
The 316th meeting of the National Heart, Lung, and Blood Advisory Council was convened on Thursday, June 25, 2026, at 1:05 p.m. as a closed virtual event. David C. Goff, M.D., Ph.D., Acting Director of the National Heart, Lung, and Blood Institute...
The National Heart, Lung, and Blood Institute (NHLBI), in partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA), hosts Research That Heals: Partnering with Patients to Transform SCD Care on June 25-26, 2026, to discuss and...